ClinicalTrials.gov
public full text
Public Domain
A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia
The purpose of this study is to evaluate the long-term safety of pomaglumetad methionil in participants with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- D-serine Monotherapy for Schizophrenia#884301
- Pharmacological and Somatic Treatments for First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines.#298739
- Fingolimod in Schizophrenia Patients#866786
- Molindone for schizophrenia and severe mental illness.#666064
- Anticholinergic Deprescription in Schizophrenia#1029742
Record · ID 848378
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive